Trichomonas vaginalis infection typically exhibits a favorable response to treatment. Nonetheless, there are instances where complete eradication proves challenging, necessitating multiple treatment cycles. Understanding patient history and conducting thorough examinations are crucial in identifying the reasons behind therapeutic failures. We present a case study involving a patient with persistent trichomoniasis despite multiple treatment cycles, attributed to the presence of an intrauterine device inserted several years prior. This case underscores the intricacies involved in managing recurrent Trichomonas vaginalis infections and the importance of a comprehensive evaluation.
RowleyJVander HoornSKorenrompE, et al.Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ2019; 97(8): 548–562.
2.
SeñaACBachmannLHHobbsMM. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Expert Rev Anti Infect Ther2014; 12(6): 673–685.
3.
SherrardJPittRHobbsKR, et al.British association for sexual health and HIV (BASHH) United Kingdom national guideline on the management of Trichomonas vaginalis 2021. Int J STD AIDS2022; 33(8): 740–750.
4.
SherrardJWilsonJDondersG, et al.2018 European (IUSTI/WHO) international union against sexually transmitted infections (IUSTI) world health organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS2018; 29(13): 1258–1272.
KiweewaFMBrownEMishraAMTN-020/ASPIRE Study Team, et al.Acquisition of sexually transmitted infections among women using a variety of contraceptive options: a prospective study among high-risk african women. J Int AIDS Soc2019; 22(2): e25257.
7.
GhallabMMIAlaaDMorsySM. Multiattribute analysis of trichomonas vaginalis diagnostics and its correlation with clinical complaints and contraceptive methods in a symptomatic Egyptian cohort. Perez-lopez FR. Infectious Dis in Obst and Gyn2021; 2021: 1–6.
8.
TamerGSKeçelSYücesoyG, et al.Doğum kontrol yöntemleri ile trichomonasis arasındaki İlişki. Türkiye Parazitoloji Dergisi. 2009; 33(4): 266–269.
9.
DuranNÇulhaGHakverdi̇AU, et al.The investigation of the association between the frequency of trichomonas vaginalis and using intrauterine contraceptive device. Trakya Univ Tip Fak Derg2009; 26(3): 197–202.
10.
PeeblesKKiweewaFMPalanee-PhillipsTMTN-020/ASPIRE Study Team, et al.Elevated risk of bacterial vaginosis among users of the copper intrauterine device: a prospective longitudinal cohort study. Clin Infect Dis2021; 73(3): 513–520.
11.
BrotmanRMKlebanoffMANanselTR, et al.Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis2010; 202(12): 1907–1915.
12.
ÁdámAPálZTerhesG, et al.Culture- and PCR-based detection of BV associated microbiological profile of the removed IUDs and correlation with the time period of IUD in place and the presence of the symptoms of genital tract infection. Ann Clin Microbiol Antimicrob2018; 17(1): 40.
13.
PálZUrbánEDósaE, et al.Biofilm formation on intrauterine devices in relation to duration of use. J Med Microbiol2005; 54(12): 1199–1203.
